Biohacker Network

Editorial Policy

Last updated: June 2025

Who writes and reviews

Every medical page displays its named author and, where appropriate, a qualified medical reviewer with stated credentials and review scope. We never invent credentials, and reviewer qualifications are represented factually.

Evidence grading

Claims are graded by the strength of underlying evidence: Strong (multiple human RCTs or meta-analyses), Moderate (limited human trials), Early clinical (small or discontinued human studies), Preclinical-dominant (primarily animal or in-vitro), and Observational (cohort or epidemiological). Human, animal, and preclinical evidence are always separated.

Citations

Numbered primary-source citations appear directly after the claims they support. We cite journals, regulatory agencies, and registries — not press releases or vendor pages.

Regulatory status first

Compound pages state FDA status early, before any discussion of effects and always before any commercial content.

Updates

Pages show published, updated, and medically-reviewed dates. We make material updates when evidence changes; we do not merely change dates to appear fresh.

Commercial separation

Editorial content is produced independently of partner relationships. See our Affiliate Disclosure.